Skip to main content

Research Repository

Advanced Search

Outcome of allografting for AML-CR2 is equivalent across BSBMT and EBMT and is associated with encouraging OS and DFS across all age groups

Byrne, Jenny; Pearce, Rachel; Perry, Julia; Crawley, C.; Jackson, Graham

Outcome of allografting for AML-CR2 is equivalent across BSBMT and EBMT and is associated with encouraging OS and DFS across all age groups Thumbnail


Authors

Jenny Byrne

Rachel Pearce

Julia Perry

C. Crawley

Graham Jackson



Citation

Byrne, J., Pearce, R., Perry, J., Crawley, C., & Jackson, G. (2019). Outcome of allografting for AML-CR2 is equivalent across BSBMT and EBMT and is associated with encouraging OS and DFS across all age groups. Bone Marrow Transplantation, 54(7), 1151-1154. https://doi.org/10.1038/s41409-019-0439-y

Journal Article Type Article
Acceptance Date Dec 31, 2018
Online Publication Date Jan 24, 2019
Publication Date Jul 1, 2019
Deposit Date Jun 12, 2019
Publicly Available Date Jul 25, 2019
Journal Bone Marrow Transplantation
Print ISSN 0268-3369
Electronic ISSN 1476-5365
Publisher Nature Publishing Group
Peer Reviewed Peer Reviewed
Volume 54
Issue 7
Pages 1151-1154
DOI https://doi.org/10.1038/s41409-019-0439-y
Public URL https://nottingham-repository.worktribe.com/output/1879767
Publisher URL https://www.nature.com/articles/s41409-019-0439-y
Additional Information Received: 9 May 2018; Revised: 17 October 2018; Accepted: 30 December 2018; First Online: 24 January 2019; : ; : The authors declare that they have no conflict of interest.
Contract Date Jun 12, 2019

Files





Downloadable Citations